COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor (REDUCE-MVI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02422888
Recruitment Status : Unknown
Verified April 2018 by Maarten van Leeuwen, VU University Medical Center.
Recruitment status was:  Active, not recruiting
First Posted : April 21, 2015
Last Update Posted : May 3, 2018
Erasmus Medical Center
Hospital San Carlos, Madrid
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University Medical Center Nijmegen
Information provided by (Responsible Party):
Maarten van Leeuwen, VU University Medical Center

No Study Results Posted on for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : October 2017
Estimated Study Completion Date : October 2019
Publications automatically indexed to this study by Identifier (NCT Number):